Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease.

[1]  Yong Liu,et al.  MiR-192-5p in the Kidney Protects Against the Development of Hypertension , 2019, Hypertension.

[2]  Eun Ji Lee,et al.  Impact of miR‐192 and miR‐194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Ming-Yang Chang,et al.  Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease. , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Lewis C. Cantley,et al.  The PI3K Pathway in Human Disease , 2017, Cell.

[5]  M. Sakaguchi,et al.  An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function , 2017, The Journal of Biological Chemistry.

[6]  P. Harris,et al.  Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. , 2017, AJP - Renal Physiology.

[7]  P. Igarashi,et al.  microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism , 2017, Nature Communications.

[8]  M. Hatley,et al.  MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.

[9]  T. Tuschl,et al.  Cell and Microvesicle Urine microRNA Deep Sequencing Profiles from Healthy Individuals: Observations with Potential Impact on Biomarker Studies , 2016, PloS one.

[10]  P. Harris,et al.  A polycystin-centric view of cyst formation and disease: the polycystins revisited , 2015, Kidney international.

[11]  G. Walz,et al.  Autosomal dominant polycystic kidney disease: the changing face of clinical management , 2015, The Lancet.

[12]  K. Bae,et al.  A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease , 2015, Kidney international.

[13]  G. Schley,et al.  Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells. , 2014, Kidney international.

[14]  S. Rosansky,et al.  Is a decline in estimated GFR an appropriate surrogate end point for renoprotection drug trials? , 2014, Kidney international.

[15]  X. Varelas,et al.  The Hippo Pathway Effectors TAZ/YAP Regulate Dicer Expression and MicroRNA Biogenesis through Let-7 , 2013, The Journal of Biological Chemistry.

[16]  A. Ong,et al.  The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre. , 2013, QJM : monthly journal of the Association of Physicians.

[17]  P. Igarashi,et al.  miR-17∼92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease , 2013, Proceedings of the National Academy of Sciences.

[18]  M. Breuning,et al.  Cyst expansion and regression in a mouse model of polycystic kidney disease. , 2013, Kidney international.

[19]  Harsh Dweep,et al.  Parallel Analysis of mRNA and microRNA Microarray Profiles to Explore Functional Regulatory Patterns in Polycystic Kidney Disease: Using PKD/Mhm Rat Model , 2013, PloS one.

[20]  Yong Liu,et al.  MicroRNAs contribute to the maintenance of cell-type-specific physiological characteristics: miR-192 targets Na+/K+-ATPase β1 , 2012, Nucleic acids research.

[21]  P. Igarashi,et al.  MicroRNAs regulate renal tubule maturation through modulation of Pkd1. , 2012, Journal of the American Society of Nephrology : JASN.

[22]  R. Sachidanandam,et al.  High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries , 2012, Nature Methods.

[23]  Mitsuo Kato,et al.  Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[24]  M. Zavolan,et al.  MicroRNA‐194 is a target of transcription factor 1 (Tcf1, HNF1α) in adult liver and controls expression of frizzled‐6 , 2012, Hepatology.

[25]  Jing Zhou,et al.  Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease , 2011, BMC Systems Biology.

[26]  Huey-Jen Lin,et al.  Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. , 2010, Cancer cell.

[27]  N. Farman,et al.  Regulation of WNK1 expression by miR-192 and aldosterone. , 2010, Journal of the American Society of Nephrology : JASN.

[28]  Huan Sun,et al.  MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation , 2010, Molecular Biology Reports.

[29]  Uyen Tran,et al.  The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity , 2010, Development.

[30]  Peter M. Rice,et al.  The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants , 2009, Nucleic acids research.

[31]  U. Tran,et al.  The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1 , 2009, Development.

[32]  Ning He,et al.  Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. , 2009, Human molecular genetics.

[33]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[34]  Benedikt Brors,et al.  Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease , 2008, BMC Genomics.

[35]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[36]  N. LaRusso,et al.  MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. , 2008, The Journal of clinical investigation.

[37]  Kimihiro Hino,et al.  Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. , 2008, RNA.

[38]  Mingyu Liang,et al.  MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. , 2008, Genome research.

[39]  M. O'hare,et al.  Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system. , 2007, Kidney international.

[40]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Y. Pei.  Nature and nurture on phenotypic variability of autosomal dominant polycystic kidney disease. , 2005, Kidney international.

[42]  D. Bartel,et al.  Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. , 2005, RNA.

[43]  Ann M. Johnson,et al.  Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[44]  Anton J. Enright,et al.  MicroRNA targets in Drosophila , 2003, Genome Biology.

[45]  Jing Zhou,et al.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells , 2003, Nature Genetics.

[46]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P Green,et al.  Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.

[50]  P. Green,et al.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.

[51]  Bradley J Erickson,et al.  Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. , 2015, Journal of the American Society of Nephrology : JASN.

[52]  K. Zen,et al.  Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. , 2014, Journal of the American Society of Nephrology : JASN.

[53]  Gang Wang,et al.  Intrarenal expression of microRNAs in patients with IgA nephropathy , 2010, Laboratory Investigation.

[54]  Gang Wang,et al.  Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. , 2010, American journal of hypertension.

[55]  Seongjoon Koo,et al.  Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. , 2004, Nucleic acids research.